INDIVIOR PHARMACEUTICALS INC (INDV) — institutional ownership
347 funds reported holding INDIVIOR PHARMACEUTICALS INC in their latest 13F filings, worth $5.17B in total (CUSIP 45579U109).
Largest holders
- BlackRock, Inc. (BLK) — $768M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $311M
- OAKTREE CAPITAL MANAGEMENT LP — $251M
- VANGUARD CAPITAL MANAGEMENT LLC — $225M
- STATE STREET CORP (STT, STT-PG) — $205M
- FULLER & THALER ASSET MANAGEMENT, INC. — $189M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $139M
- FRANKLIN RESOURCES INC (BEN) — $136M
- Two Seas Capital LP — $132M
- GEODE CAPITAL MANAGEMENT, LLC — $130M
Famous investors holding it
- Howard Marks portfolio (Oaktree Capital Management)
- Ken Griffin portfolio (Citadel Advisors)
- Izzy Englander portfolio (Millennium Management)
- Two Sigma portfolio (Two Sigma Investments)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Ray Dalio portfolio (Bridgewater Associates)
Insider buying and selling at INDIVIOR PHARMACEUTICALS INC
Who owns the most INDV stock?
The largest institutional holders in the latest 13F filings are BlackRock, Inc. (BLK) ($768M), VANGUARD PORTFOLIO MANAGEMENT LLC ($311M), OAKTREE CAPITAL MANAGEMENT LP ($251M).
How many funds own INDV?
347 funds reported holding it, worth $5.17B in total.